Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Susan Young Rojahn

A View from Susan Young Rojahn

Baby Born After Genome Analyzed in IVF Test

DNA analysis continues its baby boom.

  • July 8, 2013

In May, a baby was born after his genome was analyzed and deemed healthy during in vitro fertilization using low-cost DNA sequencing.

Private and academic researchers from the U.K. and U.S. worked with a couple in Philadelphia who had failed to conceive using another fertility treatment, according to The Guardian.  As participants in a study, the couple then tried in vitro fertilization. After uniting their sperm and egg in a dish, the couple’s doctors let the embryos grow for five days. They then plucked single cells from the resulting embryos and sent them off to the University of Oxford, where researchers used the Ion Torrent platform to screen each genome. This analysis allowed the researchers to examine each embryo for abnormal numbers of chromosomes, individual gene mutations, and mutations in the mitochondrial genome, according to an abstract from the 2013 meeting of the European Society of Human Reproduction and Embryology, where the results were announced on Monday.

Prenatal testing is a burgeoning industry for DNA sequencing technologies (see “DNA Sequencing Leader Buys into Prenatal Testing” and “Prenatal DNA Sequencing”). Couples have also been using pre-implantation diagnosis to screen their embryos for years (see “Shaping Babies”), but so far that analysis has used large-scale chromosome analysis or limited gene-specific analysis.

The tests can be too expensive for some couples, said Oxford’s Dagan Wells, lead author on the IVF study, in a release from the ESHRE.

Wells thinks that fast and cheap DNA sequencing could make such tests affordable for more families:

Many of the embryos produced during infertility treatments have no chance of becoming a baby because they carry lethal genetic abnormalities. Next generation sequencing improves our ability to detect these abnormalities and helps us identify the embryos with the best chances of producing a viable pregnancy. Potentially, this should lead to improved IVF success rates and a lower risk of miscarriage.

According to The Guardian, only three of 13 embryos from the Philadelphia couple had a normal number of chromosomes. One of the three “normal” embryos was implanted, which led to the birth of baby Connor Levy.

An earlier version of this post stated that the baby born in May was the first to have his genome sequenced as an IVF embryo, but that is not clear.

Tech Obsessive?
Become an Insider to get the story behind the story — and before anyone else.

Subscribe today

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

    Bimonthly digital/PDF edition

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special interest publications

    Discount to MIT Technology Review events

    Special discounts to select partner offerings

    Ad-free web experience

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.